ARCHIVES

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

This article is from The Cancer Letter archive.

Vol. 37 No. 46 | December 16, 2011

Download PDF Visit The Full Archive

Related Articles

Rep. Regula To Lead House Labor, HHS; Specter Likely Senate Labor, HHS Chairman.

January 12, 2001

Bush Signs Bill To Increase Blood Cancer Research.

May 17, 2002

With No Budget in Sight, NCI Takes Careful Steps; Success Rate Last Year Was 14 percent

November 18, 2011

Clinical Education Guidelines Proposed

April 4, 1975

In Brief: Senate Subcommittee Recommends $1 .52 Billion

September 25, 1987

Itri Pays Fine, Agrees Not to Serve As Company Officer for Five Years

April 25, 2014